Treating pediatric growth hormone deficiency
Pediatric growth hormone deficiency treatment consists of injections of growth hormone. Pediatric growth hormone deficiency treatment continues until the child reaches his or her adult genetic potential height or until the growing ends of the bones fuse.
Genentech products approved for the treatment of PGHD
Nutropin AQ and Nutropin are indicated for the long-term treatment of growth failure due to a lack of adequate endogenous GH secretion.
To learn more, click on the names of the products below—and be sure to discuss them and their role in pediatric growth hormone deficiency treatment with your healthcare provider.
Nutropin AQ Pen 10 for use with Nutropin AQ Pen 10 Cartridge: The latest innovation from Genentech's growth hormone product line, the Nutropin AQ Pen 10 offers simple delivery of Nutropin AQ, convenient transport, and enhanced safety features. Nutropin AQ Pen 10 is available in the U.S. by prescription only.
Nutropin AQ: A liquid GH that is premixed and ready for immediate injection. Unlike lyophilized (powdered) forms of GH, no mixing is necessary. Nutropin AQ makes GH therapy easier by eliminating about half the steps required to prepare lyophilized GH.
Nutropin: A lyophilized powder formulation that is reconstituted, or mixed, with Bacteriostatic water prior to an injection.
You should consult with your healthcare provider about the benefits and risks of Nutropin therapy.
